Terms: = Lymphoma AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729
132 results:
1. Casitas b cell lymphoma‑B (Cbl-b): A new therapeutic avenue for small-molecule immunotherapy.
Hu X; Li E; Zhou Y; You Q; Jiang Z
Bioorg Med Chem; 2024 Mar; 102():117677. PubMed ID: 38457911
[TBL] [Abstract] [Full Text] [Related]
2. CT radiomics analysis discriminates pulmonary lesions in patients with pulmonary MALT lymphoma and non-pulmonary MALT lymphoma.
Le Y; Zhu H; Ye C; Lin J; Wang N; Yang T
Methods; 2024 Apr; 224():54-62. PubMed ID: 38369073
[TBL] [Abstract] [Full Text] [Related]
3. Utility of contrast-enhanced MRI radiomics features combined with clinical indicators for predicting induction chemotherapy response in primary central nervous system lymphoma.
Wang X; Zhao L; Wang S; Zhao X; Chen L; Sun X; Liu Y; Liu J; Sun S
J Neurooncol; 2024 Feb; 166(3):451-460. PubMed ID: 38308802
[TBL] [Abstract] [Full Text] [Related]
4. E3 ubiquitin ligase casitas B-lineage lymphoma-b modulates T-cell anergic resistance via phosphoinositide 3-kinase signaling in patients with immune thrombocytopenia.
Liu L; Xiang Y; Shao L; Yuan C; Song X; Sun M; Liu Y; Zhang X; Du S; Hou M; Peng J; Shi Y
J Thromb Haemost; 2024 Apr; 22(4):1202-1214. PubMed ID: 38184203
[TBL] [Abstract] [Full Text] [Related]
5. Deep learning for [
Häggström I; Leithner D; Alvén J; Campanella G; Abusamra M; Zhang H; Chhabra S; Beer L; Haug A; Salles G; Raderer M; Staber PB; Becker A; Hricak H; Fuchs TJ; Schöder H; Mayerhoefer ME
Lancet Digit Health; 2024 Feb; 6(2):e114-e125. PubMed ID: 38135556
[TBL] [Abstract] [Full Text] [Related]
6. Performance of serum soluble interleukin-2 receptor as a diagnostic marker for lymphoma in patients with fever.
Kanda N; Yamaguchi R; Yamamoto Y; Matsumura M; Hatakeyama S
Sci Rep; 2023 Nov; 13(1):18784. PubMed ID: 37914769
[TBL] [Abstract] [Full Text] [Related]
7. Cbl-b negatively regulates TLR/MyD88-mediated anti-
Wei H; Wu S; Mai L; Yang L; Zou W; Peng H
Microbiol Spectr; 2023 Dec; 11(6):e0007423. PubMed ID: 37909781
[TBL] [Abstract] [Full Text] [Related]
8. LC-MS/MS methods for determination of venetoclax in human plasma and cerebrospinal fluid.
Yang YL; Qian ZY; Zhao Y; Chen XL; Huang QY; Guo YJ; Sun LN; Wang YQ
Biomed Chromatogr; 2023 Dec; 37(12):e5738. PubMed ID: 37724003
[TBL] [Abstract] [Full Text] [Related]
9. Trends in Survival Rates of Non-Small Cell Lung Cancer With Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020.
Chi SA; Yu H; Choi YL; Park S; Sun JM; Lee SH; Ahn JS; Ahn MJ; Choi DH; Kim K; Jung HA; Park K
JAMA Netw Open; 2023 Mar; 6(3):e232002. PubMed ID: 36929402
[TBL] [Abstract] [Full Text] [Related]
10. Survival outcomes of patients newly diagnosed with diffuse large B-cell lymphoma: real-world evidence from a German claims database.
Borchmann P; Heger JM; Mahlich J; Papadimitrious MS; Riou S; Werner B
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7091-7101. PubMed ID: 36871091
[TBL] [Abstract] [Full Text] [Related]
11. Targeting Cbl-b in cancer immunotherapy.
Augustin RC; Bao R; Luke JJ
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36750253
[TBL] [Abstract] [Full Text] [Related]
12. Clinical outcomes in patients relapsed/refractory after ≥2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis.
Kanters S; Ball G; Kahl B; Wiesinger A; Limbrick-Oldfield EH; Sudhindra A; Snider JT; Patel AR
BMC Cancer; 2023 Jan; 23(1):74. PubMed ID: 36690960
[TBL] [Abstract] [Full Text] [Related]
13. Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type.
Mehta RS; Marin D; Alousi A; Kanakry CG; Champlin RE; Rezvani K; Shpall EJ; Page K; Gadalla SM; Weisdorf D; Kebriaei P
Blood Adv; 2023 Apr; 7(8):1594-1603. PubMed ID: 36630564
[TBL] [Abstract] [Full Text] [Related]
14. Flotillin-2 regulates epidermal growth factor receptor activation, degradation by Cbl-mediated ubiquitination, and cancer growth.
Wisniewski DJ; Liyasova MS; Korrapati S; Zhang X; Ratnayake S; Chen Q; Gilbert SF; Catalano A; Voeller D; Meerzaman D; Guha U; Porat-Shliom N; Annunziata CM; Lipkowitz S
J Biol Chem; 2023 Jan; 299(1):102766. PubMed ID: 36470425
[TBL] [Abstract] [Full Text] [Related]
15. Preclinical Evaluation of CRISPR-Edited CAR-NK-92 Cells for Off-the-Shelf Treatment of AML and B-ALL.
Ureña-Bailén G; Dobrowolski JM; Hou Y; Dirlam A; Roig-Merino A; Schleicher S; Atar D; Seitz C; Feucht J; Antony JS; Mohammadian Gol T; Handgretinger R; Mezger M
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361619
[TBL] [Abstract] [Full Text] [Related]
16. Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responses.
Monticone G; Huang Z; Csibi F; Leit S; Ciccone D; Champhekar AS; Austin JE; Ucar DA; Hossain F; Ibba SV; Boulares AH; Carpino N; Xu K; Majumder S; Osborne BA; Loh C; Miele L
Front Immunol; 2022; 13():987298. PubMed ID: 36090975
[TBL] [Abstract] [Full Text] [Related]
17. Pathway importance by graph convolutional network and Shapley additive explanations in gene expression phenotype of diffuse large B-cell lymphoma.
Hayakawa J; Seki T; Kawazoe Y; Ohe K
PLoS One; 2022; 17(6):e0269570. PubMed ID: 35749395
[TBL] [Abstract] [Full Text] [Related]
18. Frailty in Patients With Newly Diagnosed Diffuse Large B-Cell lymphoma Receiving Curative-Intent Therapy: A Population-Based Study.
Vijenthira A; Mozessohn L; Nagamuthu C; Liu N; Blunt D; Alibhai S; Prica A; Cheung MC
J Natl Compr Canc Netw; 2022 Jun; 20(6):635-642.e9. PubMed ID: 35714676
[TBL] [Abstract] [Full Text] [Related]
19. Cbl-b modulated TrkA ubiquitination and function in the dorsal root ganglion of mice.
Chen HK; Li YZ; Ge AN; Zhu YB; Wu SJ; Bai X; Bai HH; Liu YN
Eur J Pharmacol; 2022 Apr; 921():174876. PubMed ID: 35288194
[TBL] [Abstract] [Full Text] [Related]
20. Association between body composition and chemotherapy-related toxicity in children with lymphoma and rhabdomyosarcoma.
Wadhwa A; Adams KM; Dai C; Richman JS; McDonald AM; Williams GR; Bhatia S
Cancer; 2022 Mar; 128(6):1302-1311. PubMed ID: 34847257
[TBL] [Abstract] [Full Text] [Related]
[Next]
